FDA clears Mobius glaucoma drug
Mitosol delivers a precise dose of its active ingredient, mitomycin-c, providing ophthalmic surgeons for use in procedures without any change to their current technique. In collaboration with St
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.